What's new

Orphan designation: Arsenic trioxide Treatment of acute promyelocytic leukaemia, 13/12/2024 Positive

Orphan designation: Arsenic trioxide Treatment of acute promyelocytic leukaemia, 13/12/2024 Positive

Feb 24, 2025 - 10:35
 0
Orphan designation: Arsenic trioxide Treatment of acute promyelocytic leukaemia, 13/12/2024 Positive
Orphan designation: Arsenic trioxide Treatment of acute promyelocytic leukaemia, 13/12/2024 Positive
Read More

Tags:

Previous Article

STAT+: Fueled by pandemic frustrations, populist parties are embracing anti-vacc...

Next Article

New World wines gain ground at Wine Paris 2025

Related Posts

Human medicines European public assessment report (EPAR): Voydeya, Danicopan, Date of authorisation: 19/04/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

EMEA-003488-PIP01-23

EMEA-003488-PIP01-23

Feb 13, 2025  0

Withdrawn application: Dupixent, 18/02/2025

Withdrawn application: Dupixent, 18/02/2025

Feb 28, 2025  0